|
Volumn 22, Issue 1, 1995, Pages 42-44
|
Treatment of chronic anti-HBe-positive hepatitis B with interferon-alpha
a a a a a a |
Author keywords
Anti HBe; Antiviral therapy; Fulminant hepatitis; HBcAg; HBeAg; HBV DNA; Hepatitis B virus; Interferon; Polymerase chain reaction; Precore mutant; Viral hepatitis
|
Indexed keywords
ALPHA2A INTERFERON;
HEPATITIS B CORE ANTIGEN;
HEPATITIS B(E) ANTIGEN;
IMMUNOGLOBULIN M;
LYMPHOBLAST INTERFERON;
VIRUS DNA;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
FEMALE;
HEPATITIS B;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
PATHOGENICITY;
POLYMERASE CHAIN REACTION;
PRIORITY JOURNAL;
VIRUS HEPATITIS;
VIRUS MUTANT;
ADOLESCENT;
ADULT;
CHILD;
CHILD, PRESCHOOL;
CHRONIC DISEASE;
CODON;
DNA, VIRAL;
FEMALE;
GENE EXPRESSION REGULATION, VIRAL;
HEPATITIS B;
HEPATITIS B E ANTIGENS;
HEPATITIS B VIRUS;
HUMANS;
INTERFERON ALFA-2A;
MALE;
MIDDLE AGED;
TREATMENT OUTCOME;
|
EID: 0028920984
PISSN: 01695185
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
Times cited : (58)
|
References (0)
|